Specialty chemical CEOs are rolling with the punches to keep their firms going

Aging equipment and plastic foam release chemicals

Chemical makers and oil producers are pulling back on production, reconsidering investments

The German firm will work with Fosun Pharma and Pfizer to develop an mRNA vaccine for COVID-19

New study explores whether dampening IL-6 could address serious coronavirus infections

Qiagen vows to ramp up production of kits as scientists turn to social media to plea for donations

Amid university shutdowns worldwide, professors and students adjust what social distancing means for lab scientists

Veterans of teaching chemistry online offer advice for professors challenged by the COVID-19 pandemic

WHO does not recommend against taking the drug for fever caused by novel coronavirus infection

Boston biotech firm is making its discovery and production service available to firms working on diagnostics, treatments, and vaccines

NO₂ levels have fallen sharply in northern Italy and China

The novel virus is one of the easiest virus types to deactivate, though SARS-CoV-2-specific data are lacking

Ammonium salts may serve as nitrogen reservoirs on the icy bodies, suggesting a common origin for comets and the sun

Chemical makers, cleaning product firms, and cosmetics makers are all scrambling to meet new limits on the impurity

Companies are making their machines and expertise available to hospitals in need of parts

Medicinal chemists focus on the main protease of SARS-CoV-2 to develop antiviral treatments for the virus causing COVID-19

Chemistry CROs are back in business as rest of world starts to lock down

The simple reaction could be an easy way to synthesize new molecules for drug discovery

Some meteorites contain superconducting alloys

Many are FDA-approved drugs that could be repurposed

Italian workers threaten to strike, but German, UK companies and workers pull together

Long-awaited image of elusive disordered tail helps scientists better understand the enzyme's mechanism

Old anti-malarial drugs have shown mixed results in the small clinical trials conducted so far

The nucleoside inhibitor has advantages over Gilead's remdesivir but has yet to be tested in humans

Qiagen vows to ramp up production of kits as scientists turn to social media to plea for donations

Companies are making their machines and expertise available to hospitals in need of parts

Medicinal chemists focus on the main protease of SARS-CoV-2 to develop antiviral treatments for COVID-19

Gilead Sciences' antiviral is in multiple late-stage trials to treat coronavirus infections. Don't expect a home run, say infectious disease experts

The National Institutes of Health receives the vast majority of the support

Activists say broad lack of enforcement threatens safety

Lingering logistic problems and a sputtering economy mean hard times for companies

US EPA finds unreasonable risks for 6 current uses, including chlor-alkali diaphragms

With a diagnostic backlog hampering disease control efforts, scientists are turning to CRISPR and other technologies to bridge the gap

Auto manufacturing is the first sector to halt demand for chemicals

These biomolecules could hold clues to why the virus is so infectious and to how to stop it

Drugmakers want to keep trials going but acknowledge that medical resources are strained

Lingering logistic problems and a sputtering economy mean hard times for companies

Editors in Europe and the US plan to work with authors whose lives and labs have been disrupted by the novel coronavirus

Long-sought phosphatetrahedrane could lead to new organophosphorus compounds

Fingers are being pointed in the Netherlands and the UK over reagent capacity constraints